Healthcare provider profile · identity verified

Edwin Anderson, MD

Family Practice · GLEN ELLYN, IL · NPI 1710935242

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	521	150
Amlodipine Besylate	Amlodipine Besylate	369	102
Levothyroxine Sodium	Levothyroxine Sodium	282	68
Lisinopril	Lisinopril	264	66
Pantoprazole Sodium	Pantoprazole Sodium	260	65
Metformin Hcl	Metformin Hcl	251	66
Losartan Potassium	Losartan Potassium	246	65
Alprazolam	Alprazolam	206	39
Hydrochlorothiazide	Hydrochlorothiazide	204	51
Metoprolol Succinate	Metoprolol Succinate	171	49
Omeprazole	Omeprazole	161	47
Tamsulosin Hcl	Tamsulosin Hcl	150	42
Simvastatin	Simvastatin	147	36
Rosuvastatin Calcium	Rosuvastatin Calcium	113	32
Gabapentin	Gabapentin	106	30
Montelukast Sodium	Montelukast Sodium	103	22
Alendronate Sodium	Alendronate Sodium	102	27
Zolpidem Tartrate	Zolpidem Tartrate	98	23
Escitalopram Oxalate	Escitalopram Oxalate	94	24
Trazodone Hcl	Trazodone Hcl	93	23
Metformin Hcl Er	Metformin Hcl	88	23
Allopurinol	Allopurinol	84	27
Albuterol Sulfate Hfa	Albuterol Sulfate	83	27
Chlorthalidone	Chlorthalidone	82	19
Ozempic	Semaglutide	82	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	80	17
Tramadol Hcl	Tramadol Hcl	78	17
Carvedilol	Carvedilol	74	19
Potassium Chloride	Potassium Chloride	72	20
Sertraline Hcl	Sertraline Hcl	69	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	67	suppressed
Pravastatin Sodium	Pravastatin Sodium	66	19
Metoprolol Tartrate	Metoprolol Tartrate	65	18
Pioglitazone Hcl	Pioglitazone Hcl	60	15
Clonazepam	Clonazepam	59	suppressed
Glipizide	Glipizide	58	19
Atenolol	Atenolol	55	14
Fluticasone Propionate	Fluticasone Propionate	53	22
Meloxicam	Meloxicam	51	13
Eliquis	Apixaban	49	suppressed
Methylprednisolone	Methylprednisolone	49	39
Furosemide	Furosemide	48	17
Triamcinolone Acetonide	Triamcinolone Acetonide	48	32
Mounjaro	Tirzepatide	46	suppressed
Bumetanide	Bumetanide	42	13
Prednisone	Prednisone	42	21
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	40	12
Duloxetine Hcl	Duloxetine Hcl	39	suppressed
Celecoxib	Celecoxib	38	19
Clopidogrel	Clopidogrel Bisulfate	38	12
Jardiance	Empagliflozin	37	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	36	suppressed
Spironolactone	Spironolactone	36	suppressed
Famotidine	Famotidine	34	12
Temazepam	Temazepam	34	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	33	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	33	suppressed
Irbesartan	Irbesartan	32	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	31	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	30	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	30	22
Benazepril Hcl	Benazepril Hcl	30	suppressed
Bupropion Xl	Bupropion Hcl	30	suppressed
Finasteride	Finasteride	29	suppressed
Levetiracetam	Levetiracetam	29	suppressed
Glipizide Er	Glipizide	28	suppressed
Azelastine Hcl	Azelastine Hcl	27	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	26	suppressed
Amoxicillin	Amoxicillin	25	20
Pregabalin	Pregabalin	25	suppressed
Hydralazine Hcl	Hydralazine Hcl	24	suppressed
Lorazepam	Lorazepam	24	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	24	suppressed
Enalapril Maleate	Enalapril Maleate	23	suppressed
Ezetimibe	Ezetimibe	23	suppressed
Klor-Con M20	Potassium Chloride	23	suppressed
Lovastatin	Lovastatin	22	suppressed
Diazepam	Diazepam	21	suppressed
Diclofenac Sodium	Diclofenac Sodium	21	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	20	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	19	suppressed
Azithromycin	Azithromycin	19	17
Citalopram Hbr	Citalopram Hydrobromide	19	suppressed
Estradiol	Estradiol	18	suppressed
Glimepiride	Glimepiride	18	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	17	suppressed
Colchicine	Colchicine	17	suppressed
Myrbetriq	Mirabegron	17	suppressed
Synthroid	Levothyroxine Sodium	17	suppressed
Tradjenta	Linagliptin	17	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Colestipol Hcl	Colestipol Hcl	15	suppressed
Digoxin	Digoxin	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Hydrocortisone	Hydrocortisone	14	suppressed
Mirtazapine	Mirtazapine	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Warfarin Sodium	Warfarin Sodium	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	12
Clobetasol Propionate	Clobetasol Propionate	13	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Ramipril	Ramipril	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Rybelsus	Semaglutide	13	suppressed
Trospium Chloride	Trospium Chloride	13	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Cefdinir	Cefdinir	12	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed
Raloxifene Hcl	Raloxifene Hcl	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error